The underlying mechanisms of the possible role of Bmal1 dysfunction in AD and associated aging‐related diseases remain unclear; increased understanding of effects of abnormal Bmal1 expression may give rise to the evolvement of new diagnostic and therapeutic approaches for better management of these diseases. Here, BMAL1 is linked to Alzheimer disease.